Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2025-12-25 @ 1:57 PM
NCT ID: NCT00433992
Description: None
Frequency Threshold: 0
Time Frame: the adverse event data was collected over the duration of the study of 96 weeks
Study: NCT00433992
Study Brief: Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
TDF/FTC HIV-infected subjects taking tenofovir DF-emtricitabine (TDF/FTC) with efavirenz (EFV) or atazanavir-lamivudine (ATV-r) 1 None 0 28 0 28 View
ABC/3TC HIV-infected subjects taking abacavir-lamivudine (ABC/3TC) 0 None 2 28 0 28 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Depression SYSTEMATIC_ASSESSMENT Psychiatric disorders None View
Other Events(If Any):